Details, Fiction and MAM-2201
This research proposes that K2's large adverse impact prevalence is owing, not less than partially, to unique JWH-018 metabolite activity on the cannabinoid 1 receptor (CB1R), and indicates that metabolites of most medications, but not the carboxy metabolite, keep in vitro and in vivo action at CB1Rs.Some unfluorinated synthesis impurities is likel